Clin2
NCT07302802Possibly a fitRecruiting

Semaglutide for weight loss in teens with genetic obesity

Monogenic Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
70 people
Ages
12 years to 21 years
Study type
Observational

Who can take part

  • You are between 12 and 21 years old.
  • You have a BMI at or above the 95th percentile for your age and sex (based on CDC growth charts).
  • You weigh more than 60 kg (about 132 lbs).
  • You have been diagnosed with monogenic obesity by a certified lab, meaning a specific gene change causes your obesity.
  • You (and your parent or guardian) agree to take part in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06380426Recruiting
Semaglutide for teens and adults with genetic obesity

This study looks at how semaglutide works in real life for people with obesity caused by a single gene change. If you or your teenager have this type of obesity and are taking or about to start semaglutide, you may be able to join.

Paris
NCT06852391Recruiting· Phase 4
Weight loss program with or without semaglutide for teens with obesity

This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.

Hamilton, Ontario
NCT07770152Not yet recruiting· Phase 4
Semaglutide for weight loss in teens with autism

This study tests whether semaglutide (a once-weekly injection that helps with weight loss) can help teenagers with autism who are obese. It will compare their results to similar teens who did not take the drug to see if it is safe and effective.

Cincinnati, Ohio
NCT06575738Recruiting· Phase 1
Semaglutide for teens after weight-loss surgery

This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.

Aurora, Colorado
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.

NCT07323134Not yet recruiting
Semaglutide for obesity and gut health

This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.

Hear when a new Monogenic Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.